SCHEMBL6922933

SCHEMBL6922933

CCC(=O)Nc1cccc(CC2(C(N)=O)CCCCC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
RAB9A P51151 2/20 0.48
POLB P06746 1/20 0.48
NR4A1 P22736 1/20 0.48
TSHR P16473 1/20 0.47
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
JAK3 P52333 1/20 0.44
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
PARP1 P09874 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5523326 0.75 CYP1A2 (0.43) RAB9ATSHRLMNAL3MBTL1SMN1; SMN2
SCHEMBL5530347 0.74 MEN1 (0.50) GAARAB9APOLBKMT2AMEN1
SCHEMBL4599573 0.74 RAB9A (0.63) GAASLC1A2SLC1A1RAB9APOLB
SCHEMBL27761563 0.74 AKR1B1 (0.41) GAAPOLBTSHRLMNAMAPT
SCHEMBL2864888 0.74 MAOA (0.46) GAARAB9ATSHRKMT2AMEN1
SCHEMBL9410518 0.74 MAPT (0.69) GAASLC1A2SLC1A1RAB9APOLB
SCHEMBL21937692 0.73 L3MBTL1 (0.48) POLBKMT2AMEN1LMNAL3MBTL1
SCHEMBL3815593 0.72 RAB9A (0.65) GAASLC1A2SLC1A1RAB9APOLB
SCHEMBL6244722 0.72 MAOA (0.47) GAARAB9ATSHRKMT2AMEN1
SCHEMBL5526973 0.72 SLC6A4 (0.50) GAAKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed